Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial
- DOI
- 10.1016/j.dld.2026.08.003
- Published
- 2026-10
- Container
- Digestive and Liver Disease
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.dld.2026.08.003,
title = {Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial},
author = {Judith Raimbourg and Damien Botsen and Simon Pernot and Valérie Boige and Mélanie Dos Santos and Clélia Coutzac and Nicolas De Sousa Carvalho and Cristina Smolenschi and Christelle de la Fouchardière},
year = {2026},
journal = {Digestive and Liver Disease},
doi = {10.1016/j.dld.2026.08.003},
url = {https://doi.org/10.1016/j.dld.2026.08.003}
}RIS
TY - JOUR TI - Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial AU - Judith Raimbourg AU - Damien Botsen AU - Simon Pernot AU - Valérie Boige AU - Mélanie Dos Santos AU - Clélia Coutzac AU - Nicolas De Sousa Carvalho AU - Cristina Smolenschi AU - Christelle de la Fouchardière PY - 2026 JO - Digestive and Liver Disease DO - 10.1016/j.dld.2026.08.003 UR - https://doi.org/10.1016/j.dld.2026.08.003 ER -
APA
Raimbourg, J., Botsen, D., Pernot, S., Boige, V., Santos, M. D., Coutzac, C., Carvalho, N. D. S., Smolenschi, C., & Fouchardière, C. D. L. (2026). Ivonescimab in combination with chemotherapy in advanced or metastatic gastric cancer (GC) or esophagogastric junction cancer (EGJC): The UCGI 52 – GRACIE trial. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2026.08.003
Source records
- crossref · retrieved 2026-09-26T04:38:16.946Z